Details

Handbook of Healthcare Analytics


Handbook of Healthcare Analytics

Theoretical Minimum for Conducting 21st Century Research on Healthcare Operations
Wiley Series in Operations Research and Management Science 1. Aufl.

von: Tinglong Dai, Sridhar Tayur

114,99 €

Verlag: Wiley
Format: PDF
Veröffentl.: 10.08.2018
ISBN/EAN: 9781119300953
Sprache: englisch
Anzahl Seiten: 480

DRM-geschütztes eBook, Sie benötigen z.B. Adobe Digital Editions und eine Adobe ID zum Lesen.

Beschreibungen

<p><b>How can analytics scholars and healthcare professionals access the most exciting and important healthcare topics and tools for the 21<sup>st</sup> century?</b></p> <p>Editors Tinglong Dai and Sridhar Tayur, aided by a team of internationally acclaimed experts, have curated this timely volume to help newcomers and seasoned researchers alike to rapidly comprehend a diverse set of thrusts and tools in this rapidly growing cross-disciplinary field. The <i>Handbook</i> covers a wide range of macro-, meso- and micro-level thrusts—such as market design, competing interests, global health, personalized medicine, residential care and concierge medicine, among others—and structures what has been a highly fragmented research area into a coherent scientific discipline.</p> <p>The handbook also provides an easy-to-comprehend introduction to five essential research tools—Markov decision process, game theory and information economics, queueing games, econometric methods, and data science—by illustrating their uses and applicability on examples from diverse healthcare settings, thus connecting tools with thrusts.</p> <p>The primary audience of the Handbook includes analytics scholars interested in healthcare and healthcare practitioners interested in analytics. This <i>Handbook</i>:</p> <ul> <li>Instills analytics scholars with a way of thinking that incorporates behavioral, incentive, and policy considerations in various healthcare settings. This change in perspective—a shift in gaze away from narrow, local and one-off operational improvement efforts that do not replicate, scale or remain sustainable—can lead to new knowledge and innovative solutions that healthcare has been seeking so desperately.</li> <li>Facilitates collaboration between healthcare experts and analytics scholar to frame and tackle their pressing concerns through appropriate modern mathematical tools designed for this very purpose.</li> </ul> <p>The handbook is designed to be accessible to the independent reader, and it may be used in a variety of settings, from a short lecture series on specific topics to a semester-long course.</p>
<p>List of Contributors xvii</p> <p>Preface xix</p> <p>Glossary of Terms xxvii</p> <p>Acknowledgments xxxv</p> <p><b>Part I Thrusts Macro-level Thrusts (MaTs)</b></p> <p><b>1 Organizational Structure 1<br /></b><i>Jay Levine</i></p> <p>1.1 Introduction to the Healthcare Industry 2</p> <p>1.2 Academic Medical Centers 6</p> <p>1.3 Community Hospitals and Physicians 16</p> <p>1.4 Conclusion 19</p> <p><b>2 Access to Healthcare 21<br /></b><i>Donald R. Fischer</i></p> <p>2.1 Introduction 21</p> <p>2.2 Goals 27</p> <p>2.3 Opportunity for Action 29</p> <p><b>3 Market Design 31<br /></b><i>Itai Ashlagi</i></p> <p>3.1 Introduction 31</p> <p>3.2 Matching Doctors to Residency Programs 31</p> <p>3.2.1 Early Days 31</p> <p>3.2.2 A Centralized Market and New Challenges 32</p> <p>3.2.3 Puzzles and Theory 33</p> <p>3.3 Kidney Exchange 35</p> <p>3.3.1 Background 35</p> <p>3.3.2 Creating a Thick Marketplace for Kidney Exchange 36</p> <p>3.3.3 Dynamic Matching 38</p> <p>3.3.4 The Marketplace for Kidney Exchange in the United States 41</p> <p>3.3.5 Final Comments on Kidney Exchange 43</p> <p>References 44</p> <p>Meso-level Thrusts (MeTs)</p> <p><b>4 Competing Interests 51<br /></b><i>Joel Goh</i></p> <p>4.1 Introduction 51</p> <p>4.2 The Literature on Competing Interests 53</p> <p>4.2.1 Evaluation of Pharmaceutical Products 53</p> <p>4.2.1.1 Individual Drug Classes 54</p> <p>4.2.1.2 Multiple Interventions 55</p> <p>4.2.1.3 Review Articles 56</p> <p>4.2.2 Physician Ownership 56</p> <p>4.2.2.1 Physician Ownership of Ancillary Services 57</p> <p>4.2.2.2 Physician Ownership of Ambulatory Surgery Centers 59</p> <p>4.2.2.3 Physician Ownership of Speciality Hospitals 60</p> <p>4.2.2.4 Physician-Owned Distributors 61</p> <p>4.2.3 Medical Reporting 62</p> <p>4.2.3.1 DRG Upcoding 63</p> <p>4.2.3.2 Non-DRG Upcoding 64</p> <p>4.3 Examples 65</p> <p>4.3.1 Example 1: Physician Decisions with Competing Interests 66</p> <p>4.3.2 Example 2: Evidence of HAI Upcoding 70</p> <p>4.4 Summary and FutureWork 72</p> <p>References 73</p> <p><b>5 Quality of Care 79<br /></b><i>Hummy Song and Senthil Veeraraghavan</i></p> <p>5.1 Frameworks for Measuring Healthcare Quality 79</p> <p>5.1.1 The Donabedian Model 79</p> <p>5.1.2 The AHRQ Framework 81</p> <p>5.2 Understanding Healthcare Quality: Classification of the Existing</p> <p>OR/MS Literature 82</p> <p>5.2.1 Structure 82</p> <p>5.2.2 Process 85</p> <p>5.2.3 Outcome 91</p> <p>5.2.4 Patient Experience 92</p> <p>5.2.5 Access 94</p> <p>5.3 Open Areas for Future Research 95</p> <p>5.3.1 Understanding Structures and Their Interactions with Processes and Outcomes 95</p> <p>5.3.2 Understanding Patient Experiences and Their Interactions with Structure 96</p> <p>5.3.3 Understanding Processes andTheir Interactions with Outcomes 97</p> <p>5.3.4 Understanding Access to Care 98</p> <p>5.4 Conclusions 98</p> <p>Acknowledgments 99</p> <p>References 99</p> <p><b>6 Personalized Medicine 109<br /></b><i>Turgay Ayer and Qiushi Chen</i></p> <p>6.1 Introduction 109</p> <p>6.2 Sequential Decision Disease Models with Health Information Updates 111</p> <p>6.2.1 Case Study: POMDP Model for Personalized Breast Cancer Screening 113</p> <p>6.2.2 Case Study: Kalman Filter for Glaucoma Monitoring 116</p> <p>6.2.3 Other Relevant Studies 118</p> <p>6.3 One-Time Decision Disease Models with Risk Stratification 120</p> <p>6.3.1 Case Study: Subtype-Based Treatment for DLBCL 121</p> <p>6.3.2 Other Applications 124</p> <p>6.4 Artificial Intelligence-Based Approaches 125</p> <p>6.4.1 Learning from Existing Health Data 126</p> <p>6.4.2 Learning from Trial and Error 127</p> <p>6.5 Conclusions and Emerging Future Research Directions 128</p> <p>References 130</p> <p><b>7 Global Health 137<br /></b><i>Karthik V. Natarajan and Jayashankar M. Swaminathan</i></p> <p>7.1 Introduction 137</p> <p>7.2 Funding Allocation in Global Health Settings 139</p> <p>7.2.1 Funding Allocation for Disease Prevention 139</p> <p>7.2.2 Funding Allocation for Treatment of Disease Conditions 143</p> <p>7.2.2.1 Service Settings 143</p> <p>7.2.2.2 Product Settings 146</p> <p>7.3 Inventory Allocation in Global Health Settings 147</p> <p>7.3.1 Inventory Allocation for Disease Prevention 147</p> <p>7.3.2 Inventory Allocation for Treatment of Disease Conditions 149</p> <p>7.4 Capacity Allocation in Global Health Settings 153</p> <p>7.5 Conclusions and Future Directions 155</p> <p>References 156</p> <p><b>8 Healthcare Supply Chain 159<br /></b><i>Soo-Haeng Cho and Hui Zhao</i></p> <p>8.1 Introduction 159</p> <p>8.2 Literature Review 162</p> <p>8.3 Model and Analysis 164</p> <p>8.3.1 Generic Injectable Drug Supply Chain 164</p> <p>8.3.1.1 Model 166</p> <p>8.3.1.2 Analysis 168</p> <p>8.3.2 Influenza Vaccine Supply Chain 171</p> <p>8.3.2.1 Model 172</p> <p>8.3.2.2 Analysis 173</p> <p>8.4 Discussion and Future Research 177</p> <p>Appendix 180</p> <p>Acknowledgment 182</p> <p>References 182</p> <p><b>9 Organ Transplantation 187<br /></b><i>Bar</i><i>𝚤¸s Ata, John J. Friedewald and A. CemRanda</i></p> <p>9.1 Introduction 187</p> <p>9.2 The Deceased-Donor Organ Allocation system: Stakeholders and Their Objectives 189</p> <p>9.3 Research Opportunities in the Area 199</p> <p>9.3.1 Past Research on the Transplant Candidate’s Problem 199</p> <p>9.3.2 Challenges in Modeling Patient Choice 201</p> <p>9.3.3 Past Research on the Deceased-donor Organ Allocation Policy 202</p> <p>9.3.4 Challenges in Modeling the Deceased-donor Organ Allocation Policy 206</p> <p>9.3.5 Research Problems from the Perspective of Other Stakeholders 206</p> <p>9.4 Concluding Remarks 208</p> <p>References 209</p> <p>Micro-level Thrusts (MiTs)</p> <p><b>10 Ambulatory Care 217<br /></b><i>Nan Liu</i></p> <p>10.1 Introduction 217</p> <p>10.2 How Operations are Managed in Primary Care Practice 218</p> <p>10.3 What Makes Operations Management Difficult in Ambulatory Care 220</p> <p>10.3.1 Competing Objectives 220</p> <p>10.3.2 Environmental Factors 221</p> <p>10.4 Operations Management Models 222</p> <p>10.4.1 System-Wide Planning 222</p> <p>10.4.2 Appointment Template Design 226</p> <p>10.4.3 Managing Patient Flow 231</p> <p>10.5 New Trends in Ambulatory Care 234</p> <p>10.5.1 Online Market 234</p> <p>10.5.2 Telehealth 235</p> <p>10.5.3 Retail Approach of Outpatient Care 236</p> <p>10.6 Conclusion 237</p> <p>References 237</p> <p><b>11 Inpatient Care 243<br /></b><i>Van-Anh Truong</i></p> <p>11.1 Modeling the Inpatient Ward 244</p> <p>11.2 Inpatient Ward Policies 246</p> <p>11.3 Interface with ED 247</p> <p>11.4 Interface with Elective Surgeries 248</p> <p>11.5 Discharge Planning 250</p> <p>11.6 Incentive, Behavioral, and Organizational Issues 251</p> <p>11.7 Future Directions 252</p> <p>11.7.1 Essential Quantitative Tools 253</p> <p>11.7.2 Resources for Learners 253</p> <p>References 253</p> <p><b>12 Residential Care 257<br /></b><i>Nadia Lahrichi, Louis-Martin Rousseau and Willem-Jan van Hoeve</i></p> <p>12.1 Overview of Home Care Delivery 257</p> <p>12.1.1 Home Care 258</p> <p>12.1.2 Home Healthcare 258</p> <p>12.1.2.1 Temporary Care 259</p> <p>12.1.2.2 Specialized Programs 259</p> <p>12.1.3 Operational Challenges 260</p> <p>12.1.3.1 Discussion of the Planning Horizon 262</p> <p>12.1.3.2 Home Care Planning Problem 263</p> <p>12.2 An Overview of Optimization Technology 263</p> <p>12.2.1 Linear Programming 263</p> <p>12.2.2 Mixed Integer Programming 264</p> <p>12.2.3 Constraint Programming 265</p> <p>12.2.4 Heuristics and Dedicated Methods 265</p> <p>12.2.5 Technology Comparison 266</p> <p>12.2.5.1 Solution Expectations and Solver Capabilities 266</p> <p>12.2.5.2 Development Time and Maintenance 267</p> <p>12.3 Territory Districting 267</p> <p>12.4 Provider-to-Patient Assignment 270</p> <p>12.4.1 Workload Measures 270</p> <p>12.4.2 Workload Balance 271</p> <p>12.4.3 Assignment Models 272</p> <p>12.4.4 Assignment of New Patients 273</p> <p>12.5 Task Scheduling and Routing 273</p> <p>12.6 Perspectives 276</p> <p>12.6.1 Integrated Decision-Making Under a New Business Model 277</p> <p>12.6.2 Home Telemetering Forecasting Adverse Events 277</p> <p>12.6.3 Forecasting the Wound Healing Process 278</p> <p>12.6.4 Adjustment of Capacity and Demand 279</p> <p>References 280</p> <p><b>13 ConciergeMedicine 287<br /></b><i>Srinagesh Gavirneni and Vidyadhar G. Kulkarni</i></p> <p>13.1 Introduction 287</p> <p>13.2 Model Setup 291</p> <p>13.3 Concierge Option—No Abandonment 293</p> <p>13.3.1 A Given Participation Level 𝛼 294</p> <p>13.3.2 How to choose d? 295</p> <p>13.3.2.1 All Customers Are Better Off 295</p> <p>13.3.2.2 Customers Are Better Off on Average 297</p> <p>13.3.3 Optimal Participation Level 299</p> <p>13.4 Concierge Option—Abandonment 301</p> <p>13.4.1 Choosing the Optimal 𝛼 and 𝛽 303</p> <p>13.5 Correlated Service Times and Waiting Costs 304</p> <p>13.6 MDVIP Adoption 306</p> <p>13.6.1 The Data 307</p> <p>13.6.2 AbandonmentModel Applied to MDVIP Data 308</p> <p>13.6.2.1 Modeling Heterogeneous Waiting Costs 309</p> <p>13.6.2.2 Participation in Concierge Medicine 310</p> <p>13.6.2.3 Impact of Concierge Medicine 310</p> <p>13.6.2.4 Choosing the Concierge Participation Level 312</p> <p>13.7 Research Opportunities 313</p> <p>References 316</p> <p><b>Part II Tools</b></p> <p><b>14 Markov Decision Processes 319<br /></b><i>Alan Scheller-Wolf</i></p> <p>14.1 Introduction 319</p> <p>14.2 Modeling 321</p> <p>14.3 Types of Results 325</p> <p>14.3.1 Numerical Results 325</p> <p>14.3.2 Analytical Results 327</p> <p>14.3.3 Insights 328</p> <p>14.4 Modifications and Extensions of MDPs 328</p> <p>14.4.1 Imperfect State Information 328</p> <p>14.4.2 Extremely Large or Continuous State Spaces 329</p> <p>14.4.3 Uncertainty about Transition Probabilities 330</p> <p>14.4.4 Constrained Optimization 331</p> <p>14.5 Future Applications 332</p> <p>14.6 Recommendations for Additional Reading 333</p> <p>References 334</p> <p><b>15 Game Theory and Information Economics 337<br /></b><i>Tinglong Dai</i></p> <p>15.1 Introduction 337</p> <p>15.2 Key Concepts 339</p> <p>15.2.1 GameTheory: Key Concepts 339</p> <p>15.2.2 Information Economics: Key Concepts 340</p> <p>15.2.2.1 Nonobservability of Information 341</p> <p>15.2.2.2 Asymmetric Information 341</p> <p>15.3 Summary of Healthcare Applications 343</p> <p>15.3.1 Incentive Design for Healthcare Providers 344</p> <p>15.3.2 Quality-Speed Tradeoff 345</p> <p>15.3.3 Gatekeepers 346</p> <p>15.3.4 Healthcare Supply Chain 346</p> <p>15.3.5 Vaccination 346</p> <p>15.3.6 Organ Transplantation 347</p> <p>15.3.7 Healthcare Network 347</p> <p>15.3.8 Mixed Motives of Healthcare Providers 347</p> <p>15.4 Potential Applications 348</p> <p>15.4.1 Micro-Level applications 348</p> <p>15.4.2 Macro-Level Applications 349</p> <p>15.4.3 Meso-Level Applications 349</p> <p>15.5 Resources for Learners 351</p> <p>References 351</p> <p><b>16 Queueing Games 355<br /></b><i>Mustafa Akan</i></p> <p>16.1 Introduction 355</p> <p>16.1.1 Scope of the Review 356</p> <p>16.2 Basic QueueingModels 356</p> <p>16.2.1 Components of a Queueing System 356</p> <p>16.2.2 Performance Measures 357</p> <p>16.2.3 M/M/1 358</p> <p>16.2.4 M/G/1 359</p> <p>16.2.5 M/M/c 360</p> <p>16.2.6 Priorities 361</p> <p>16.2.6.1 Achievable Region Approach 363</p> <p>16.2.7 Networks of Queues 364</p> <p>16.2.8 Approximations 364</p> <p>16.3 Strategic Queueing 365</p> <p>16.3.1 Waiting as an Equilibrium Device 366</p> <p>16.3.2 Demand Dependent on Service Time 367</p> <p>16.3.3 Physician-Induced Demand 369</p> <p>16.3.4 Joining the Queue 370</p> <p>16.3.4.1 Observable Queue 370</p> <p>16.3.4.2 Unobservable Queue 371</p> <p>16.3.5 Waiting for a Better Match 373</p> <p>16.4 Discussion and Future Research Directions 376</p> <p>References 376</p> <p><b>17 EconometricMethods 381<br /></b><i>Diwas KC</i></p> <p>17.1 Introduction 381</p> <p>17.2 Statistical Modeling 382</p> <p>17.2.1 Statistical Inference 383</p> <p>17.2.2 Biased Estimates 384</p> <p>17.3 The Experimental Ideal and the Search for Exogenous Variation 386</p> <p>17.3.1 Instrumental Variables 386</p> <p>17.3.1.1 Example 1 (IV): Patient Flow through an Intensive Care Unit 388</p> <p>17.3.1.2 Example 2 (IV): Focused Factories 391</p> <p>17.3.2 Difference Estimators 392</p> <p>17.3.3 Fixed Effects Estimators 394</p> <p>17.3.3.1 Examples 3-4 (D-in-D): Process Compliance and Peer Effects of Productivity 395</p> <p>17.4 Structural Estimation 395</p> <p>17.4.1 Example 5: Managing Operating Room Capacity 396</p> <p>17.4.2 Example 6: Patient Choice Modeling 397</p> <p>17.5 Conclusion 399</p> <p>References 400</p> <p><b>18 Data Science 403<br /></b><i>Rema Padman</i></p> <p>18.1 Introduction 403</p> <p>18.1.1 Background 404</p> <p>18.1.2 Methods 407</p> <p>18.1.3 Attribute Selection and Ranking 408</p> <p>18.1.4 Information Gain (IG) Attribute Ranking 408</p> <p>18.1.5 Relief-F Attribute Ranking 408</p> <p>18.1.6 Markov Blanket Feature Selection 408</p> <p>18.1.7 Correlation-Based Feature Selection 409</p> <p>18.1.8 Classification 409</p> <p>18.2 Three Illustrative Examples of Data Science in Healthcare 410</p> <p>18.2.1 Medication Reconciliation 410</p> <p>18.2.2 Dynamic Prediction of Medical Risks 413</p> <p>18.2.3 Practice-Based Clinical Pathway Learning 416</p> <p>18.3 Discussion 419</p> <p>18.3.1 Challenges and Opportunities 419</p> <p>18.3.2 Data Science in Action 420</p> <p>18.3.3 Health Data ScienceWorldwide 421</p> <p>18.4 Conclusions 421</p> <p>References 422</p> <p>Index 429</p>
<p><b>Tinglong Dai, PhD,</b> is Associate Professor of Operations Management and Business Analytics at Johns Hopkins University. A recipient of numerous awards, including Johns Hopkins Discovery Award, Institute for Operations Research and the Management Sciences (INFORMS) Public Sector Operations Research Best Paper Award and Production and Operations Management Society (POMS) Best Healthcare Paper Award, his research spans across healthcare analytics, marketing/operations interfaces, and artificial intelligence. <p><b>Sridhar Tayur, PhD,</b> is Ford Distinguished Research Chair and Professor of Operations Management at Tepper School of Business, Carnegie Mellon University. He has been elected as Member of National Academy of Engineering, Fellow of Institute for Operations Research and the Management Sciences (INFORMS), and Distinguished Fellow of the Manufacturing and Service Operations Management Society (MSOM). An Academic Capitalist, he is Founder of the supply chain software company SmartOps and the social enterprise OrganJet.
<p>"Healthcare markets are in need of redesign. This timely Handbook showcases what analytics have to offer."</br> —<b>Alvin E. Roth,</b> Nobel Laureate in Economics Craig and Susan McCaw Professor of Economics at Stanford University <p><b>How can analytics scholars and healthcare professionals access the most exciting and important healthcare topics and tools for the 21st century?</b> <p>Editors Tinglong Dai and Sridhar Tayur, aided by a team of internationally acclaimed experts, have curated this timely volume to help newcomers and seasoned researchers alike to rapidly comprehend a diverse set of thrusts and tools in this rapidly growing cross-disciplinary field. The Handbook covers a wide range of macro-, meso- and micro-level thrusts—such as market design, competing interests, global health, personalized medicine, residential care and concierge medicine, among others—and structures what has been a highly fragmented research area into a coherent scientific discipline. <p>The handbook also provides an easy-to-comprehend introduction to five essential research tools—Markov decision process, game theory and information economics, queueing games, econometric methods, and data science—by illustrating their uses and applicability on examples from diverse healthcare settings, thus connecting tools with thrusts. <p>The primary audience of the Handbook includes analytics scholars interested in healthcare and healthcare practitioners interested in analytics. This Handbook: <ul> <li>Instills analytics scholars with a way of thinking that incorporates behavioral, incentive, and policy considerations in various healthcare settings. This change in perspective—a shift in gaze away from narrow, local and one-off operational improvement efforts that do not replicate, scale or remain sustainable—can lead to new knowledge and innovative solutions that society has been seeking so desperately.</li> <li>Facilitates collaboration between healthcare experts and analytics scholar to frame and tackle their pressing concerns through appropriate modern mathematical tools designed for this very purpose.</li> </ul> <p>The handbook is designed to be accessible to the independent reader, and it may be used in a variety of settings, from a short lecture series on specific topics to a semester-long course.

Diese Produkte könnten Sie auch interessieren:

Implementing Beyond Budgeting
Implementing Beyond Budgeting
von: Bjarte Bogsnes
PDF ebook
33,99 €
Pricing Done Right
Pricing Done Right
von: Tim J. Smith
EPUB ebook
52,99 €
Pricing Done Right
Pricing Done Right
von: Tim J. Smith
PDF ebook
52,99 €